Bio tech company updates — 5/19/2026
This health signal was created by a user. It may contain unverified medical claims. Always consult a qualified healthcare professional before making health decisions.
Korean biotech developments continue to generate headlines, with CHA Biotech signing a strategic MOU with Thermo Fisher Scientific Korea to establish the K-Bio-CIC Open Innovation Center in Pangyo. Fresh coverage from Korea Biomed (published May 18) highlights this partnership as a significant step toward building a collaborative open innovation hub for the Korean biotech ecosystem. Limited fresh data is available for today's 24-hour window, but the CHA Biotech–Thermo Fisher deal stands out as the most recently reported story.
Key Findings
- CHA Biotech × Thermo Fisher Korea MOU: CHA Biotech has signed a strategic memorandum of understanding (MOU) with Thermo Fisher Scientific Korea to establish and operate the K-Bio-CIC Open Innovation Center, to be located in Pangyo. This was reported by Korea Biomed on May 18, 2026.
Details
The K-Bio-CIC Open Innovation Center, planned for Pangyo — South Korea's major biotech corridor — represents a collaboration between domestic biotech firm CHA Biotech and global life sciences company Thermo Fisher Scientific Korea. The center is intended to serve as a hub for open innovation within Korea's biotech sector, though further operational details have not yet been disclosed as of this report.
No other Korea biotech stories with confirmed publication dates after 2026-05-17 were identified in the available research results for this issue.
Sources
- Korea Biomed — CHA Biotech, Thermo Fisher Korea MOU announcement (May 18, 2026):
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
